The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
ZS6dJk5mT8m0EqwC
